Sigma 1 Receptor and Its Pivotal Role in Neurological Disorders

Faculty Pharmacy Year: 2024
Type of Publication: ZU Hosted Pages:
Authors:
Journal: ACS Pharmacol Transl Sci . American Chemical Society. Volume:
Keywords : Sigma , Receptor , , Pivotal Role , Neurological Disorders    
Abstract:
Sigma 1 receptor (S1R) is a multifunctional, ligand-activated protein located in the membranes of the endoplasmic reticulum (ER). It mediates a variety of neurological disorders, including epilepsy, amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease. The wide neuroprotective effects of S1R agonists are achieved by a variety of pro-survival and antiapoptotic S1R-mediated signaling functions. Nonetheless, relatively little is known about the specific molecular mechanisms underlying S1R activity. Many studies on S1R protein have highlighted the importance of maintaining normal cellular homeostasis through its control of calcium and lipid exchange between the ER and mitochondria, ER-stress response, and many other mechanisms. In this review, we will discuss S1R different cellular localization and explain S1R-associated biological activity, such as its localization in the ER-plasma membrane and Mitochondrion-Associated ER Membrane interfaces. While outlining the cellular mechanisms and important binding partners involved in these processes, we also explained how the dysregulation of these pathways contributes to neurodegenerative disorders.
   
     
 
       

Author Related Publications

  • Shimaa Mostafa Mostafa Elshazly, "The selective 5-LOX inhibitor 11-keto-β-boswellic acid protects against myocardial ischemia reperfusion injury in rats: involvement of redox and inflammatory cascades", Naunyn-Schmiedeberg's Arch Pharmacol, 2012 More
  • Shimaa Mostafa Mostafa Elshazly, "Anticancer activity of salicin and fenofibrate.", zagizag, 2017 More
  • Shimaa Mostafa Mostafa Elshazly, "Pentoxifylline abrogates cardiotoxicity induced by the administration of a single high dose or multiple low doses of doxorubicin in rats", Can J Physiol Pharmacol, 2016 More
  • Shimaa Mostafa Mostafa Elshazly, "Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats.", Springer-Verlag Berlin Heidelberg, 2015 More
  • Shimaa Mostafa Mostafa Elshazly, "Insights in the mechanism underlying the protective effect of α-lipoic acid against acetaminophen-hepatotoxicity.", elsevier, 2015 More

Department Related Publications

  • Eman Salah Abdelaziz Souliman, "Cannabinoids as Therapeutics for Non-Melanoma and Melanoma Skin Cancer", J scimed central, 2016 More
  • Israa Mohamed Nagib Mohamed Zakarya, "PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals", Elsevier, 2016 More
  • Hany Mohamed Abdelmalek Mahmoud ElBassossy, "PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals", Elsevier, 2016 More
  • Ahmed Fahmy Ahmad, "PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals", Elsevier, 2016 More
  • Amro Abdelraof Abdelghany Mahmoud, "Cinnamaldehyde Mitigates Carbon Tetrachloride-induced Acute Liver Injury in Rats Through Inhibition of Toll-like Receptor 4 Signaling Pathway", Asian Network for Scientific Information, 2016 More
Tweet